HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Somatostatin analogue and tissue cultures in the study of a human malignant glucagonoma.

Abstract
A patient with metastasizing glucagonoma producing multiple molecular forms of glucagon is reported. The patient responded to symptomatic treatment with a somatostatin analogue (SMS 201-995). Glucagonoma tumour cells were studied in two tissue culture systems: intraocular transplants of immunosuppressed rats and long-term cell cultures. In both systems, several region-specific glucagon antisera gave a positive immunoreaction with tumour cells indicating synthesis of multiple molecular species. Intraocular tumour transplants released glucagon into the chamber fluid. In animals with unilateral transplants, glucagon was also detected in the contralateral eye chamber, indicating passage from the transplants via unknown mechanisms. Treatment of tumour cells during culture with SMS 201-995 inhibited rapidly the spontaneous release of glucagon without evident cytotoxic effects. The inhibitory effect decreased with time.
AuthorsH Ahlman, L Ahlund, A Dahlström, L Grimelius, E Theodorsson
JournalJournal of surgical oncology (J Surg Oncol) Vol. 44 Issue 3 Pg. 191-9 (Jul 1990) ISSN: 0022-4790 [Print] United States
PMID2164620 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Glucagon
  • Octreotide
Topics
  • Adenoma, Islet Cell (drug therapy)
  • Animals
  • Chromatography, Gel
  • Female
  • Glucagon (analysis, metabolism)
  • Glucagonoma (drug therapy, metabolism, secondary)
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Neoplasm Transplantation
  • Octreotide (therapeutic use)
  • Pancreatic Neoplasms (drug therapy, metabolism)
  • Radioimmunoassay
  • Rats
  • Rats, Inbred Strains
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: